SRX 0.00% 17.5¢ sierra rutile holdings limited

SRX vs BTG, page-22

  1. 61 Posts.
    Regarding NAN:

    It is an interesting concept, and appears to have some institutional support. I first heard about this several weeks ago. However, ultrasound technology has been used as a point of care device in various subspecialties for over ten years. Initially used for diagnosis, and more recently for interventional procedures. Although novel, it is not clear there is a need, or any significant need, for this in current medical practice.

    (Disclosure: this is the opinion of a specialist who has published and presented locally and internationally on ultrasound-related applications.)
 
watchlist Created with Sketch. Add SRX (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.